Connect with us

Business

Tauriga Sciences, Inc. (OTCMKTS: TAUG) Sets up a Clinical Trial to Determine the effects of Cannabidiol on Pregnant Women with a Hyperemesis Gravidarum Diagnosis.

Published

on

Nausea and vomiting are very common in early pregnancy, and the victims have to ingest multiple medications. About 5% of them are known to consume some form of cannabinoid. The bad news is that little is known about its effectiveness to both the mother and the developing fetuses. However, the good news is that Tauriga Sciences, Inc. (OTCMKTS: TAUG) has commenced a clinical trial to ascertain the effects of Cannabidiol on pregnant women. 

Women with Hyperemesis Gravidarum diagnosis will form the primary subjects of the trial. They must also have Excessive First Trimester Emesis. Unlike alcohol, there is no known congenital disability identified to have been caused by CBD or THC. Additionally, pregnant women are hardly subjects of clinical trials presenting demanding scientific data despite being a vulnerable population. 

Nonetheless, Dr. Keith Aqua Tauriga’s Chief Medical Officer explained, “…We intend to add to the fund of knowledge regarding the effects of CBD on pregnant women by performing this and other scientific clinical trials.”

The Launch of Tauriga’s Pharmaceutical Development Initiative 

The New York-based diversified Life Sciences Company boasts several business activities, initiatives, and activities, including manufacturing and distributing proprietary retail products and product lines. A proprietary supplement chewing gum branded as Tauri-Gum is the main product line. 

All these retail businesses compliment Tauriga’s ongoing Pharmaceutical Development initiatives. This makes it the only company evaluating Cannabidiol concerning pregnant women. And if all right, the industry may result in the making pharmaceutical-grade version of Tauri-Gum for nausea regulation. 

Tauriga Sciences, Inc.Renews its US Federal Government Vendor Status

The company successfully obtained a US Federal Government Vendor status in early October 2020. This status has expanded to extraordinary heights, enhancing its diversification of products and product lines. And having identified multiple potential government contract opportunities, the company has renewed its status.

Tauriga works directly with FAMR, an independent consulting firm specializing in identifying future opportunities before Registration, Certification, and Federal Contracting.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

FEATURED STORIES

Business15 seconds ago

Tauriga Sciences, Inc. (OTCMKTS: TAUG) Sets up a Clinical Trial to Determine the effects of Cannabidiol on Pregnant Women with a Hyperemesis Gravidarum Diagnosis.

Post Views: 2 Nausea and vomiting are very common in early pregnancy, and the victims have to ingest multiple medications....

Business13 mins ago

BetterLife Pharma Inc. (OTCMKTS: BETRF) Announce Initiation Of In Vitro Studies of AP-003 Against The Delta Variant of SARS-CoV-2

Post Views: 2 Depression impacts approximately 265 million people in the world. According to WHO, it is one of the...

Business20 mins ago

Ayr Wellness Inc. (OTCMKTS: AYRWF) Signs a Binding Letter of Intent to Acquire PA Natural Medicine, LLC

Post Views: 6 Curiosity about cannabis is building by the day as more expert cultivators, manufactures, budtenders, and patient consultants...

Business31 mins ago

Schwazze (OTCMKTS: SHWZ) Spends $6.7 Million to Acquire the Assets of Brow 2, LLC, Located in Denver, Colorado

Post Views: 14 Innovative thinking is what will keep the next era of the cannabis industry alive. This is according...

Business19 hours ago

Valens Company Inc (OTCMKTS: VLNCF) Acquires Leading, Premium Craft Licensed producer, Citizen Stash Cannabis Corp

Post Views: 87 Valens Company Inc (OTCMKTS: VLNCF), a leading manufacturer of cannabis products, announced that it entered into an...

Business19 hours ago

Harvest One Cannabis Inc’s (OTCMKTS: HRVOF) Dream Water Brand Launches its Sleep Gummies into the American Market

Post Views: 92 Harvest One Cannabis Inc (OTCMKTS: HRVOF) reported that its Dream Water launched sleep gummies for a new...